Financhill
Back

BioXcel Therapeutics Quote, Financials, Valuation and Earnings

BioXcel Therapeutics Price Quote

$18.31
-0.01 (0.33%)
(Updated: March 25, 2023 at 5:13 AM ET)

BioXcel Therapeutics Key Stats

Sell
33
BioXcel Therapeutics (BTAI) is a Sell

Day range:
$17.60 - $18.38
52-week range:
$8.80 - $34.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.92%

Volume:
586.7K
Avg. volume:
581.9K
1-year change:
-16.19%
Market cap:
$531.5M
Revenue:
$375K
EPS:
$-5.91

How Much Does BioXcel Therapeutics Make?

Data Unavailable

Is BioXcel Therapeutics Growing As A Company?

Data Unavailable

BioXcel Therapeutics Stock Price Performance

What Is BioXcel Therapeutics 52-Week High & Low?

BioXcel Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioXcel Therapeutics?

Is BioXcel Therapeutics Cash Flow Positive?

  • What Is BTAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$135.3M
  • What Is BioXcel Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $96.2M
  • What Is BioXcel Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$139K

BioXcel Therapeutics Return On Invested Capital

Data Unavailable

BioXcel Therapeutics Earnings Date & Stock Price

BioXcel Therapeutics Competitors

BioXcel Therapeutics Dividend Yield

Data Unavailable

BioXcel Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -37.99%
Revenue: 0% -77.93%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 52.80
Upside from Last Price: 188.21%

Major Shareholders

  • How many BTAI shares are owned by institutional investors?
    22.9M BTAI shares are owned by institutional investors
  • How many BTAI shares are owned by insiders?
    139.6K BTAI shares are owned by insiders